We are a boutique consulting firm specialised in pharmaceutical strategy — advising governments, sovereign funds, and institutional investors on building self-sufficient pharma ecosystems.
Engage MacKaoui →Deep pharmaceutical domain expertise paired with institutional strategy — delivering actionable intelligence for national health security and market access.
National API manufacturing strategy, import substitution roadmaps, regulatory infrastructure design, and technology transfer for self-sufficient pharma ecosystems.
Clinical trial infrastructure design, drug development pipeline optimization, GMP/GACP manufacturing strategy, and biotech ecosystem architecture from lab to market.
Pharmaceutical free zone design, export platform strategy, regulatory affairs (EMA, FDA, WHO, ANVISA), and market access frameworks for emerging economies.
Capital stack structuring, project finance for pharma infrastructure, JV architecture (51/49 frameworks), and institutional investor engagement strategies.
End-to-end pharmaceutical logistics architecture, cold chain infrastructure planning, strategic stockpile design, and resilience modeling for essential medicines.
Healthcare system architecture, digital health infrastructure, pharmaceutical governance frameworks, and national health security strategy for cabinet-level clients.
In-depth analysis of pharmaceutical sovereignty, biotech ecosystems, and industrial policy — produced monthly for institutional decision-makers.
A comprehensive 30-year strategic framework for building a sovereign pharmaceutical bridge between China, Morocco, and Africa. Covers market intelligence, ecosystem design, JV architecture, financial modeling, regulatory diplomacy, and continental expansion across 14 chapters.
Market entry strategies for the ECOWAS pharmaceutical market — regulatory harmonization, distribution architecture, and partnership models for 350M+ population across 15 member states.
A 23-component ecosystem design for Morocco's pharmaceutical transformation — spanning 7 specialised hubs, technology transfer frameworks, and digital infrastructure requirements.
Fiscal, regulatory, and infrastructure framework for establishing pharmaceutical free economic zones — drawing on precedents from Suzhou, Hyderabad, and RAK.
Strategic stockpile design, cold chain infrastructure planning, API independence roadmap, and resilience metrics for Morocco's essential medicine security.
A boutique approach refined across 38 sovereign engagements — from deep diagnosis through strategy and execution.
Deep institutional audit of existing pharmaceutical infrastructure, regulatory environment, supply chain vulnerabilities, and human capital readiness.
Comprehensive strategic blueprint: investment thesis, phasing architecture, regulatory roadmap, technology transfer framework, and stakeholder alignment.
Operational implementation support: project finance structuring, JV architecture, partner selection, regulatory navigation, and institutional capacity building.
For sovereign engagements, institutional partnerships, and specialised pharma strategy — reach our team directly.
Boutique pharma strategy advisory. Serving sovereign clients, institutional investors, and emerging-market governments since 2018.